Liaoning Cheng Da Co 600739.SS · CNY

Its shares trade on Shanghai under the ticker 600739.SS. It has been listed since 19 August 1996. In the fiscal year to 31 December 2025, it reported revenue of CN¥9.90bn and net income of CN¥736.6m. At that date it held total assets of CN¥49.07bn and shareholders' equity of CN¥28.78bn.

Liaoning Cheng Da Co., Ltd. engages in the commodities distribution, import and export trading as well as biological drug manufacturing. The company is headquartered in Dalian, Liaoning. The firm operates through four segments. The Commodity Trading segment is engaged in the retailing and wholesales of pharmaceuticals, as well as the trading of oil, coal and steel, among others. The Biopharmaceutical Manufacturing segment is engaged in the research and development, production and marketing of vaccines for human and animals. The Energy Development segment is engaged in the exploitation, production and sales of oil. The Financial Services segment is engaged in long-term investment businesses and fund businesses. The firm operates its businesses in both domestic and overseas markets.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Biao XuChairman of the Board, since 2020CN¥80,000
• Mr. Shuzhi ShangHonorary Chairman, since 2018CN¥1.6m
• Mr. Shanwei ZhangPresident, Director, since 2021CN¥1.5m
• Ms. Lu WangChief Financial Officer
• Mr. Heng LiChief Compliance Officer, Acting Secretary of the BoardCN¥1.1m
• Mr. Shaohui PeiVice PresidentCN¥419,800
• Mr. Chuang QiuVice President
• Mr. Bin WangVice PresidentCN¥1.4m
• Mr. Yue ZhouVice President
• Mr. Hao ZhuVice PresidentCN¥1.5m
• Mr. Zhihua LiuDirector
• Mr. Dongbo QuDirectorCN¥80,000

Overall

35

Environment

46

Social

24

Governance

36

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.